During this period, cancer research shifted toward mechanism-based explanations of oncogenesis and therapy. Researchers leveraged in vitro cell culture systems, early three-dimensional tumor models, and quantitative analyses of metastasis to understand cancer biology with increasing precision. Monoclonal antibodies began to emerge as diagnostic and therapeutic tools, and natural products with defined molecular targets signaled the rise of mechanism-guided drug discovery, including inhibitors of DNA enzymes.